Page last updated: 2024-09-03
gefitinib and diosmin
gefitinib has been researched along with diosmin in 1 studies
Compound Research Comparison
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (diosmin) | Trials (diosmin) | Recent Studies (post-2010) (diosmin) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 540 | 106 | 243 |
Protein Interaction Comparison
Protein | Taxonomy | gefitinib (IC50) | diosmin (IC50) |
---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 3.89 | |
Aurora kinase B | Homo sapiens (human) | 9.14 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Other Studies
1 other study(ies) available for gefitinib and diosmin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |